The SMYD4 gene is demonstrated to be a potential tumor suppressor and plays a critical role in breast carcinogenesis, at least partly through inhibiting the expression of platelet-derived growth factor receptor-alpha (PDGFRA), and this gene could be a novel target for improving the treatment of breast cancer [39]. The gene discussed is PDGFRA; the disease is breast cancer.